Literature DB >> 26745142

Psychosocial Results from a Phase I Trial of a Nonsurgical Circumcision Device for Adult Men in Zimbabwe.

Danuta Kasprzyk1,2, Daniel E Montaño1,2, Deven T Hamilton2, Kayla L Down3, Karl D Marrett4, Mufuta Tshimanga5,6, Sinokuthemba Xaba6, Owen Mugurungi6.   

Abstract

Male circumcision (MC), an effective HIV prevention tool, has been added to Zimbabwe's Ministry of Health and Child Care HIV/AIDS Prevention Program. A Phase I safety trial of a nonsurgical male circumcision device was conducted and extensive psychosocial variables were assessed. Fifty-three men (18 and older) were recruited for the device procedure; 13 follow-up clinical visits were completed. Interviews conducted three times (before the procedure, at 2 weeks and 90 days post-procedure) assessed: Satisfaction; expectations; actual experience; activities of daily living; sexual behavior; and HIV risk perception. Using the Integrated Behavioral Model, attitudes towards MC, sex, and condoms, and sources of social influence and support were also assessed. Men (mean age 32.5, range 18-50; mean years of education = 13.6; 55% employed) were satisfied with device circumcision results. Men understand that MC is only partially protective against HIV acquisition. Most (94.7%) agreed that they will continue to use condoms to protect themselves from HIV. Pain ratings were surprisingly negative for a procedure billed as painless. Men talked to many social networks members about their MC experience; post-procedure (mean of 14 individuals). Minimal impact on activities of daily living and absenteeism indicate possible cost savings of device circumcisions. Spontaneous erections occurred frequently post-procedure. The results had important implications for changes in the pre-procedure clinical counseling protocol. Clear-cut counseling to manage pain and erection expectations should result in improved psychosocial outcomes in future roll-out of device circumcisions. Men's expectations must be managed through evidence-based counseling, as they share their experiences broadly among their social networks.

Entities:  

Mesh:

Year:  2016        PMID: 26745142      PMCID: PMC4717523          DOI: 10.1089/apc.2015.0111

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  16 in total

Review 1.  Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections.

Authors:  Aaron A R Tobian; Seema Kacker; Thomas C Quinn
Journal:  Annu Rev Med       Date:  2013-09-16       Impact factor: 13.739

2.  Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings.

Authors:  Jean Paul Bitega; Muyenzi Leon Ngeruka; Theobald Hategekimana; Anita Asiimwe; Agnes Binagwaho
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-15       Impact factor: 3.731

3.  Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

Authors:  Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

4.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Authors:  Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

Review 5.  Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review.

Authors:  N Westercamp; R C Bailey
Journal:  AIDS Behav       Date:  2006-10-20

Review 6.  Toward a Systematic Approach to Generating Demand for Voluntary Medical Male Circumcision: Insights and Results From Field Studies.

Authors:  Sema K Sgaier; James Baer; Daniel C Rutz; Emmanuel Njeuhmeli; Kim Seifert-Ahanda; Paulin Basinga; Rosie Parkyn; Catharine Laube
Journal:  Glob Health Sci Pract       Date:  2015-06-17

7.  Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys.

Authors:  Bertran Auvert; Dirk Taljaard; Dino Rech; Pascale Lissouba; Beverley Singh; Julie Bouscaillou; Gilles Peytavin; Séverin Guy Mahiane; Rémi Sitta; Adrian Puren; David Lewis
Journal:  PLoS Med       Date:  2013-09-03       Impact factor: 11.069

8.  The cost and impact of male circumcision on HIV/AIDS in Botswana.

Authors:  Lori A Bollinger; John Stover; Godfrey Musuka; Boga Fidzani; Themba Moeti; Lesego Busang
Journal:  J Int AIDS Soc       Date:  2009-05-27       Impact factor: 5.396

9.  The PrePex device is unlikely to achieve cost-savings compared to the forceps-guided method in male circumcision programs in sub-Saharan Africa.

Authors:  Walter Obiero; Marisa R Young; Robert C Bailey
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

10.  Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa.

Authors:  Timothy B Hallett; Kanwarjit Singh; Jennifer A Smith; Richard G White; Laith J Abu-Raddad; Geoff P Garnett
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.